Infinium Global Research Cephalosporin Drugs Market | Page 3

cephalosporin and Fifth-generation cephalosporin. Moreover, the global cephalosporin drugs market is
segmented based on route of drug administration into Injection and Oral. The injection segment is accounted for
the most preferred route of drug administration as it results in quick drug delivery.
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia Pacific, Latin
America and Rest of the World (RoW). Asia pacific is accounted for the largest share of market in the global
cephalosporin drugs market. Asia Pacific continued its dominance by covering more than 50% market share
between 2014 and 2017. Increasing demand for highly developed healthcare infrastructure, increasing awareness
about cephalosporin’s drugs among the patients and benefits associated with it are expected to be the key factors
supporting the growth of this region over the forecast period. North America is considered to be the most
attractive market by region over the forecast period and anticipated to grow at the highest CAGR due to rising
prevalence in infectious diseases in the region.
Companies Profiled:
The companies covered in the report include Allergan, Astellas, Bristol-Myers Squibb, GSK, Merck, Abbott, Aspen
Pharmacare, AstraZeneca, Johnson & Johnson, Sun Pharmaceutical, Orchid Pharma, Theravance Biopharma,
Pfizer, Baxter, Basilea Pharmaceuticals, Incepta Pharmacueticals, Sandoz and others.
Make an Enquiry
https://www.infiniumglobalresearch.com/reports/enquiry/85
Report Highlights:
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In
addition, this report provides insights on the factors that are driving and restraining the demand of cephalosporin
drugs globally as well as regionally. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on
the investment areas that existing or new market players can consider. The report provides insights into the
Infinium Global Research